The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant μ-opioid receptors and SH-SY5Y cells

British Journal of Pharmacology

Volumn 128, Issue 2, 1999, Pages 472-478

  Harrison, C ^a   McNulty, S ^b   Smart, D ^b,e   Rowbotham, D J ^a   Grandy, D K ^c   Devi, L A ^d   Lambert, D G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cyclic AMP; Endomorphin; Intracellular calcium; Opioid receptor

Indexed keywords

CALCIUM ION; CYCLIC AMP; DIPRENORPHINE; ENDOMORPHIN 1; ENDOMORPHIN 2; FORSKOLIN; MU OPIATE RECEPTOR; NALOXONE; OPIATE RECEPTOR; RECOMBINANT RECEPTOR; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CALCIUM CELL LEVEL; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; BINDING, COMPETITIVE; CALCIUM; CELL MEMBRANE; CHO CELLS; CRICETINAE; CYCLIC AMP; DIPRENORPHINE; FORSKOLIN; OLIGOPEPTIDES; RATS; RECEPTORS, OPIOID, MU; RECOMBINANT PROTEINS;

EID: 0032837591     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702798     Document Type: Article

References (47)

1. ALT, A., MANSOUR, A., AKIL, H., MEDZHIRADSKY, F., TRAYNOR, J.R. & WOODS, J.H. (1998). Stimulation of guanasine-5″-O-(3-[S-35]thio)triphosphate binding by endogenous opioids acting at a cloned μ-opioid receptor. J. Pharmacol. Exp. Ther., 286, 282-288.
2. BRADBURY, A.F., SMYTHI, D.G. & SNELL, C.R. (1976). C fragment of lipotropin has a high affinity for brain opiate receptors. Nature, 260, 793-795.
3. BROWN, B.L., ALBANO, J.D.M., EKINS, R.D. & SGHERZI, A.M. (1971). A simple and sensitive assay method for the measurement of adenosine 3′:5′-cyclic monophosphate. Biochem. J., 121, 516-522.
4. BURFORD, N.L., TOLBERT, L.M. & SADEE, W. (1998). Specific G-protein activation and μ-opioid receptor internalization caused by morphine, DAMGO and endomorphin-1. Eur. J. Pharmacol., 341, 123-126.
5. CHAMPION, H.C., ZADINA, J.E., KASTIN, A.J., HACKLER, L., GE, L.J. & KADOWITZ, P.J. (1997a). The endogenous μ-opioid receptor agonists endomorphin-1 and 2 have novel hypotensive activity in the rabbit. Biochem. Biophys. Res. Com., 235, 567-570.
6. CHAMPION H.C., ZADINA, J.E., KASTIN, A.J., HACKLER, L., GE., L.J. & KADOWITZ, P.J. (1997b). Endomorphin-1 and -2, endogenous ligands for the endogenous μ-opioid receptor, decrease cardiac output, and total periferal resistance in the rat. Peptides, 18, 1393-1397.
7. CHAMPION, H.C., ZADINA, J.E., KASTIN, A.J. & KADOWITZ, P.J. (1997c). The endogenous μ-opioid receptor agonists, endomorphin-1 and -2 have vasodilator activity in the hindquarters vascular bed of the rat. Life Sci, 61, PL409-PL415.
8. CHAPMAN, V., DIAZ, A. & DICKENSON, A.H. (1997). Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat. Br. J. Pharmacol, 122, 1537-1539.
9. CHILDERS, S.R. (1991). Opioid receptor coupled second messenger systems. Life Sci., 48, 1991-2003.
10. CONNOR, M. & HENDERSON, G. (1996). δ- and μ-opioid mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol., 117, 333-340.
11. CZAPLA, M.A., CHAMPION, H.C., ZADINA, J.E., KASLIN, A.J., HACKLER, L., GE, L.J. & KADOWITZ, P.J. (1998). Endomorphin-1 and -2, endogenous μ-opioid receptor agonists, decrease systemic arterial pressure in the rat. Life Sci., 62, PL175-PL179.
12. EVANS, C.J., KEITH, D.F., MORRISON, H., MAGENDZO, K. & EDWARDS, R.H. (1992). Cloning of a delta-opioid receptor by Functional expression. Science, 258, 1952-1955.
13. GOLDBERG, I.E., ROSSI, G.C., LETCHWORTH, S.R., MATHIS, J.P., RYAN-MORO, J., LEVENTHAL, L., SU, W., EMMEL, D., BOLAN, E. & PASTERNAK, G.W. (1998). Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther., 286, 1007-1013.
14. GOLDSTEIN, A., TACHIBANA, S., LOWNEY, L.I., HUNKAPILLER, M. & HOOD, L. (1979). Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U.S.A., 76, 6666-6670.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
16. HACKLER, L., ZADINA, J.E., GE, L.J. & KASTIN, A.J. (1997). Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides, 18, 1635-1639.
17. HARRISON, C., ROBOTHAM, D.J., DEVI, L.A. & LAMBERT, D.G. (1997). Activation of the δ-opioid receptor expressed in Chinese hamster ovary cells increases intra-cellular calcium. Br. J. Pharmacol., 120, 222P.
18. HARRISON, C., SMART, D. & LAMBERT, D.G. (1998a). Stimulatory effects of opioids. Br. J. Anacs., 81, 20-28.
19. HARRISON, L.M., KASTIN, J.A. & ZADINA, J.E. (1998b.). Differential effects of endomorphin-1, endomorphin-2 and Try-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes. Peptides, 19, 749-753.
20. 2+ channel currents in rodent NG108 cells overexpressing μ-opioid receptors. J. Physiol., 50, 771-775.
21. HIRST, R.A. & LAMBERT, D.G. (1995). Adenylyl cyclase in SH-SY5Y human neuroblastoma cells is regulated by intra- and extracellular calcium. Biochem. Pharmacol., 49, 1633-1640.
22. HOSOSHAT, K., BURKEY, T.H., ALFERO-LOPEZ, J., VARGA, E., HRUBY, V.J., ROESKE, W.R. & YAMAMURA, H.I. (1998). Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptor. Eur. J. Pharmacol., 346, 111-114.
23. HUGHES, J., SMITH, T.W., FOTHERGILI, L.A., MORGAN, B.A., MORRIS, H.R. & KOSTERLITZ, H.W. (1975). Identification of two related peptides from the brain with potent opiate agonist activity. Nature, 258, 577-579.
24. INGRAM, S.L. & WILLIAMS, J.T. (1994). Opioid inhibition of I-h via adenylyl-cyclase. Neuron, 13, 179-186.
25. 35S]GTPγS binding by endomorphin-1 and DAMGO in mouse brain. Peptides, 19, 755-758.
26. KIEFFER, B., BEFORT, K., GAVERIAUX-RUFF, C. & HIRTH, C.G. (1992). The delta-opioid receptor: isolation of cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A., 89, 12048-12052.
27. KNAPP, R.J., MALATYNSKA, E., COLLINS, N., FANG, L., WANG, J.Y., HRUBY, V.J., ROESKE, W.R. & YAMAMURA, H.I. (1995). Molecular biology and pharmacology of cloned opioid receptors. FASEB J., 9, 516-525.
28. 3H]noradrenaline release from SH-SY5Y cells. Biochem. Pharmacol., 46, 1145-1150.
29. MARTIN-SCHILD, S., ZADINA, J.E. GERALL, A.A., VIGH, S. & KASTIN, A. (1997). Localization of endomorphin-2-like immunoreactivity in rat medulla and spinal cord. Peptides, 18, 1641-1649.
30. 2+ channel inhibition by endomorphins via the cloned μ-opioid receptor expressed in NG108-15 cells. Eur. J. Pharmacol., 340, R1-R2.
31. NORTH, R.A. (1989). Drug receptors and the inhibition of nerve cells. Br. J. Pharmacol., 98, 13-28.
32. 2+ system through cross-talk between opioid receptors and P2 purinergic or bradykinin receptors in NG108-15 cells. Biochem. J., 290, 241-247.
33. PIERCE, T.L., GRAHEK, M.D. & WESSENDORF, M.W. (1998). Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkeys. Neuroreport, 9, 385-389.
34. PORZIG, H. (1990). Pharmacological modulation of voltage dependent calcium channels in intact cells. Rev. Physiol. Biochem. Pharmacol., 114, 209-262.
35. SARNE, Y. & GAFNI, M. (1996). Determinants of the stimulatory opioid effect on intracellular calcium in SK-N-SH and NG 108 15 neuroblastoma. Brain Res., 722, 203-206.
36. SARNE, Y., FIELDS, A., KAREN, O. & GAFNI, M. (1996). Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results. Neurochem. Res., 11, 1353-1361.
37. SCHREFF, M., SCHULZ, S., WIBORNY, D & HOLLT, V. (1998). Immunofluorescent identification of endomorphin-2-containing nerve fibres and terminals in the rat brain and spinal cord. Neuroreport, 9, 1031-1034.
38. 35S]GTPγS binding in rut brain; evidence for partial agonist activity at μ-opioid receptors. J. Neurochem., 70, 1567-1576.
39. SMART, D. & LAMBERT, D.G. (1996). The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol. Sci., 17, 264-269.
40. i and adenylyl cyclase. Br. J. Pharmacol., 120, 1165-1171.
41. SMART, D., SMITH, G. & LAMBERT, D.G. (1995). μ-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium channel opening. J. Biochem., 305, 577-582.
42. 2a, cells by activation of multiple opioid receptor subtypes. Biochem. Pharmacol., 54, 809-818.
43. STONE, L.S, FAIRBANKS, C.A., LAUGHLIN, T.M., NGUYEN, H.O., BUSHY, T.M., WESSENDORF, M.W. & WILCOX, G.L. (1997). Spinal analgesic actions of the new endogenous opioid peptides of endomorphin-1 and endomorphin-2. Neuroreport, 8, 3131-3135.
44. THOMPSON, R.C., MANSOUR, A., AKIL, H. & WATSON, S.J. (1993). Cloning and pharmacological characterization of a rat μ-opioid receptor. Neuron, 11, 903-913.
45. WANDLESS, A., SMART, D. & LAMBERT, D.G. (1996). Fentanyl increases intracellular calcium concentration in SH-SY5Y cells. Br. J. Anaes., 76, 461-463.
46. YASUDA, K., RAYNOR, K., KONG, H., BREDEER, C.D., TAKEDA, J., BELL, G.I. & REISINE, T. (1993). Cloning and functional comparison of kappa-opioid and delta-opioid receptors from mouse-brain. Proc. Natl. Acad. Sci. U.S.A., 90, 6736-6740.
47. ZADINA, J.E., HACKLER, L., GE, U.J. & KASTIN, A.J. (1997). A potent and selective endogenous agonist for the μ-opioid receptor. Nature, 386, 499-502.